LIVE

FORA

Forian Inc.

FORA

NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $67.8M

$2.17

0.00%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$1.64 - $2.71

P/E

-13.06

Fwd P/E

-54.25

Beta

0.93

Div Yield

0.00%

Avg Vol

29.5K

Shares Out

31.2M

Mkt Cap

$67.8M

Price action

Price chart

Up 5.8% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary seed-to-sale traceability technology deeply embedded in cannabis operations
  • Regulatory relationships and government agency partnerships for compliance systems
  • Vertically integrated software ecosystem reducing customer switching costs
  • Predictive analytics and data insights derived from extensive healthcare and cannabis operational data

Bear Case

1 risk

  • Average volatility.

Growth

Stable outlook

Cannabis industry legalization and expansion across U.S. states and Canada

Value

Deep value opportunity - significant discount to Healthcare IT & Services peers

Momentum

Stable

+4.3% over 3m

Quality

Strong

Strong fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 13, 2026

Q2 26 RECAP

MAY 15, 2026

Reported EPS of -$0.09 vs $0.02 consensus (-550.0% surprise). Revenue of $6.9M vs $7.6M expected (-10.1%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 2 beats

Q2 26

-550.0%

Q2 26

-650.0%

Next: May 13, 2026

Revenue trend · last 8Q

+45%

+56%

+66%

+37%

-3%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$4.8M

$4.7M

$5.8M

$7.1M

$7.5M

$7.8M

$8.0M

$6.9M

Margins · last 8Q

Gross

Operating

Profit

-49.1%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

vs Industry

How FORA stacks vs Medical - Healthcare Information Services

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.